ArticleJHEP reports : innovation in hepatology2025

A novel therapy targeting the gut-liver axis for chronic hepatitis B: Ursodeoxycholic acid plus

Zhen Xun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.